← Open Payments lookup

MELISSA RUDD: Open Payments

NPI 1124131776 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,226 in 60 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $114 · 2025 $1,226

Food & beverage: $1,226
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.15$192
Otsuka America Pharmaceutical, Inc.15$166
E.R. Squibb & Sons, L.L.C.4$164
Neurocrine BioSciences, Inc.7$160
Gilead Sciences, Inc.1$131
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$116
Alkermes, Inc.4$70
Vanda Pharmaceuticals Inc.2$55
Axsome Therapeutics, Inc.2$52
Merck Sharp & Dohme LLC2$48

Products named: REXULTI, COBENFY, INGREZZA, CAPLYTA, UZEDY, AUSTEDO XR, FANAPT, ARISTADA.

Industry payments across FL — which companies pay providers there.